BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Jovanović M, Vučićević K, Miljković B. Understanding variability in the pharmacokinetics of atypical antipsychotics - focus on clozapine, olanzapine and aripiprazole population models. Drug Metab Rev 2020;52:1-18. [PMID: 32008418 DOI: 10.1080/03602532.2020.1717517] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Lee J, Kim MG, Jeong HC, Shin KH. Physiologically-based pharmacokinetic model for clozapine in Korean patients with schizophrenia. Transl Clin Pharmacol 2021;29:33-44. [PMID: 33854999 DOI: 10.12793/tcp.2021.29.e3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Azorin J, Simon N. Antipsychotic polypharmacy in schizophrenia: evolving evidence and rationale. Expert Opinion on Drug Metabolism & Toxicology 2020;16:1175-86. [DOI: 10.1080/17425255.2020.1821646] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
3 Suhas S, Kumar V, Damodharan D, Sharma P, Rao NP, Varambally S, Venkatasubramanian G, Murthy P, Gangadhar BN. Do Indian patients with schizophrenia need half the recommended clozapine dose to achieve therapeutic serum level? Schizophr Res. 2020;222:195-201. [PMID: 32518001 DOI: 10.1016/j.schres.2020.05.057] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
4 Moschny N, Hefner G, Grohmann R, Eckermann G, Maier HB, Seifert J, Heck J, Francis F, Bleich S, Toto S, Meissner C. Therapeutic Drug Monitoring of Second- and Third-Generation Antipsychotic Drugs-Influence of Smoking Behavior and Inflammation on Pharmacokinetics. Pharmaceuticals (Basel) 2021;14:514. [PMID: 34071813 DOI: 10.3390/ph14060514] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Yartsev A, Peisah C. Caffeine-clozapine interaction associated with severe toxicity and multiorgan system failure: a case report. BMC Psychiatry 2021;21:192. [PMID: 33849480 DOI: 10.1186/s12888-021-03199-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
6 Xiao T, Wang Z, Li G, Huang S, Zhu X, Liu S, Li X, Hu J, Shang D, Wen Y. What to Do About Missed Doses? A Retrospective Study of Olanzapine in the Elderly. Drug Des Devel Ther 2021;15:3411-23. [PMID: 34376974 DOI: 10.2147/DDDT.S316110] [Reference Citation Analysis]
7 McGrane IR, Lindbloom TJ, Munjal RC. Possible inhibitory effects of terbinafine on aripiprazole metabolism: Two case reports. Ment Health Clin 2021;11:297-300. [PMID: 34621606 DOI: 10.9740/mhc.2021.09.297] [Reference Citation Analysis]
8 Davis MP, Sanger GJ. The Benefits of Olanzapine in Palliating Symptoms. Curr Treat Options Oncol 2020;22:5. [PMID: 33244634 DOI: 10.1007/s11864-020-00804-1] [Reference Citation Analysis]